RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.04
+0.16%0
Insider buys (3m)
14
Insider sells (3m)
-$123.1M
Net value (3m)
+39.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Rahmer Peter · officer: See remarks | Sale | 4,508 | $20 |
| Aug 28, 2026 | SVF Pauling (Cayman) Ltd · 10 percent owner | Sale | 6,000,000 | $19 |
| Aug 18, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | Sale | 17,717 | $20 |
| Aug 18, 2026 | Patel Sanjiv · director, officer: President and CEO | Sale | 48,199 | $20 |
| Jul 30, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | Sale | 1,459 | $19 |
| Jul 30, 2026 | Rahmer Peter · officer: See remarks | Sale | 748 | $19 |
| Jul 30, 2026 | Bergstrom Donald A · officer: President, R&D | Sale | 2,237 | $19 |
| Jul 8, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | Sale | 17,717 | $19 |
| Jul 8, 2026 | Bergstrom Donald A · officer: President, R&D | Sale | 8,660 | $19 |
| Jul 8, 2026 | Patel Sanjiv · director, officer: President and CEO | A-Award | 3,056 | $6.95 |
| Jul 8, 2026 | Patel Sanjiv · director, officer: President and CEO | Sale | 48,199 | $20 |
| Jul 2, 2026 | Rahmer Peter · officer: See remarks | A-Award | 3,056 | $6.95 |
| Jul 2, 2026 | Rahmer Peter · officer: See remarks | Sale | 50,000 | $19 |
| Jun 24, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | Sale | 17,717 | $17 |
| Jun 24, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | Sale | 51,560 | $17 |
| Jun 24, 2026 | Bergstrom Donald A · officer: President, R&D | Sale | 93,456 | $17 |
| Jun 24, 2026 | Bergstrom Donald A · officer: President, R&D | M-Exempt | 93,456 | $4.12 |
| Jun 24, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | M-Exempt | 51,560 | $4.45 |
| Jun 24, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | M-Exempt | 61,563 | $5.22 |
| Jun 24, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | M-Exempt | 56,323 | $5.04 |
| Jun 10, 2026 | COATS LONNEL · director | A-Award | 32,947 | $14 |
| Jun 10, 2026 | HILL LINDA A · director | A-Award | 32,947 | $14 |
| Jun 10, 2026 | Dable Habib J · director | A-Award | 32,947 | $14 |
| Jun 10, 2026 | Mazumdar Claire · director | A-Award | 32,947 | $14 |
| Jun 10, 2026 | Borisy Alexis · director | A-Award | 32,947 | $14 |
| Jun 10, 2026 | INGRAM DOUGLAS S · director | A-Award | 32,947 | $14 |
| Jun 10, 2026 | Murcko Mark · director | A-Award | 32,947 | $14 |
| May 14, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | Sale | 17,717 | $13 |
| Apr 30, 2026 | Catinazzo Thomas · officer: Chief Financial Officer | Sale | 972 | $15 |
| Apr 30, 2026 | Bergstrom Donald A · officer: President, R&D | Sale | 1,490 | $15 |
Institutional positioning
13F filings over the trailing two quarters
New 104Increased 211Reduced 119Sold out 31
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | Unchanged | 27,904,963 | May 18, 2026 |
| SB INVESTMENT ADVISERS (UK) LTD | Unchanged | 27,904,963 | Aug 14, 2026 |
| FMR LLC | Increased | 20,110,113 | Aug 13, 2026 |
| COMMODORE CAPITAL LP | Unchanged | 17,000,000 | May 15, 2026 |
| Casdin Capital, LLC | Increased | 16,035,240 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 15,288,202 | Aug 7, 2026 |
| CASDIN CAPITAL, LLC | Increased | 14,418,574 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 14,106,187 | Aug 14, 2026 |
| BLACKROCK, INC. | Reduced | 12,975,299 | May 13, 2026 |
| Commodore Capital LP | Reduced | 12,000,000 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 10,125,381 | Aug 7, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 9,751,141 | May 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 8,964,423 | Aug 13, 2026 |
| BELLEVUE GROUP AG | Reduced | 7,795,242 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 7,708,507 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 28, 2026